Inhibitory activity of constitutive nitric oxide on the expression of alpha/beta interferon genes in murine peritoneal macrophages

Journal of Virology

Volumn 73, Issue 9, 1999, Pages 7328-7333

  Guillemard, Eric ^a,b   Varano, Barbara ^a   Belardelli, Filippo ^a   Quero, A M ^b   Gessani, Sandra ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; MESSENGER RNA; N(G) NITROARGININE; NITRIC OXIDE;

ADOLESCENT; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALOMYOCARDITIS VIRUS; FEMALE; GENE EXPRESSION REGULATION; GENE REPRESSION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0032816156     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.9.7328-7333.1999     Document Type: Article

References (48)

1. Akaike, T., M. Suga, and H. Maeda. 1998. Free radicals in viral pathogenesis: molecular mechanisms involving Superoxide and NO. PSEBM (Proc. Soc. Exp. Biol. Med.) 217:64-73.
2. Akaike, T., Y. Noguchi, S. Ijiri, K. Setoguchi, M. Suga, Y. M. Zheng, B. Dietzschold, and H. Maeda. 1996. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 93:2448-2453.
3. Au, W.-C, Y. Su, N. B. Raj, and P. M. Pitha. 1993. Virus-mediated induction of interferon A gene requires cooperation between multiple binding factors in the interferon-α promoter region. J. Biol. Chem. 268:24032-24040.
4. Bauer, H., T. Jung, D. Tsikas, D. O. Stichtenoth, J. C. Frölich, and C. Neumann. 1997. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology 90: 205-211.
5. Belardelli, F., F. Vignaux, E. Proietti, and I. Gresser. 1984. Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus. Proc. Natl. Acad. Sci. USA 81:602-606.
6. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rytter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
7. Deguchi, M., K. Inaba, and S. Muramatsu. 1995. Counteracting effect of interferon-gamma-induced production of nitric oxide which is suppressive for antibody response. Immunol. Lett. 45:157-162.
8. Forstermann, U., J. P. Boissel, and H. Kleinert. 1998. Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 12:773-790.
9. Fujita, T., Y. Kimura, M. Miyamoto, E. L. Barsoumian, and T. Taniguchi. 1989. Induction of endogenous IFN-α and IFN-α genes by a regulatory transcription factor, IRF-1. Nature 337:270-272.
10. Gendelman, H. E., J. Zheng, C. L. Coulter, A. Ghorpade, M. Che, M. Thylin, R. Rubocki, Y. Persidsky, F. Hahn, J. Reinhand, Jr., and S. Swindells. 1998. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J. Infect. Dis. 178:1000-1007.
11. Gessani, S., C. W. Dieffenbach, L. Conti, P. Di Marzio, K. L. Wilson, and F. Belardelli. 1993. Selective alteration of the turnover of interferon β mRNA in peritoneal macrophages from LPS-hyporesponsive mice and its role in the defective expression of spontaneous interferon. Virology 193:507-509.
12. Gessani, S., P. Puddu, B. Varano, P. Borghi, L. Conti, L. Fantuzzi, and F. Belardelli. 1994. Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replicaticn. J. Virol. 68:1983-1986.
13. Giovannoni, G., R. F. Miller, S. J. Heales, J. M. Land, M. J. Harrison, and E. J. Thompson. 1998. Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: a correlation with blood-brain-barrier dysfunction. J. Neurol. Sci. 156:53-58.
14. Gresser, I., C. Maury, T. Kaido, M. T. Bandu, M. G. Tovey, M. T. Maunoury, L. Fantuzzi, S. Gessani, G. Greco, and F. Belardelli. 1995. The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells. Int. J. Cancer 63:726-731.
15. Guillemard, E., M. Geniteau-Legendre, B. Mabboux, I. Poilane, R. Kergot, G. Lemaire, J. F. Petit, C. Labarre, and A. M. Quero. 1993. Antiviral action of trehalose dimycolale against EMC virus: role of macrophages and interferon α/β. Antiviral Res. 22:201-213.
16. Guillemard, E., M. Geniteau-Legendre, R. Kergot, G. Lemaire, J. F. Petit, C. Labarre, and A. M. Quero. 1995. Role of TDM-induced interferon α/β in the restriction of EMC virus growth in vivo and in peritoneal macrophage cultures. Antiviral Res. 28:175-189.
17. Guillemard, E., M. Geniteau-Legendre, R. Kergot, G. Lemaire, S. Gessani, C. Labarre, and A.-M. Quero. 1998. Simultaneous Production of IFN-γ, IFN-α/β and Nitric Oxide in Peritoneal Macrophages from TDM-Treated Mice. J. Biol. Regul. Homeostatic Agents 12:67-75.
18. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, M. Maruyama, A. Furia, T. Mivata, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729-739.
19. Ito, M., M. Watanabe, H. Kamiya, and M. Sakurai. 1996. Inhibition of natural killer (NK) cell activity against varicella-zoster virus (VZV)-infected fibroblasts and lymphocyte activation in response to VZV antigen by nitric oxide-releasing agents. Clin. Exp. Immunol. 106:40-44.
20. Ito, M., M. Watanabe, H. Kamiya, and M. Sakurai. 1996. Inhibition of natural killer cell activity against cytomegalovirus-infected fibroblasts by nitric oxide-releasing agents. Cell. Immunol. 174:13-18.
21. Kamijo, R., H. Harada, T. Matsujama, M. Bosland, J. Gerecitanoshapiro, J. Le, S. I. Koh, T. Kimura, S. J. Green, T. W. Mak, T. Taniguchi, and J. Vilcek. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612-1615.
22. Karupiah, G., J. H. Chen, S. Mahalingam, C. F. Nathan, and J. D. MacMicking. 1998. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J. Exp. Med. 188:1541-1546.
23. Kreil, T. R., and M. M. Eibl.1996. Nitric oxide and viral infection: no antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. Virology 219:304-306.
24. Lane, T. E., A. D. Paoletti, D. Paoletti, and M. J. Buchmeier. 1997. Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J. Virol. 71:2202-2210.
25. Lenardo, M. J., C.-M. Fang, T. Maniatis, and D. Baltimore. 1989. The involvement of NF-KB in β-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57:287-294.
26. Lòpez-Collazo, E., S. Hortelano, A. Rojas, and L. Bosca. 1998. Triggering of peritoneal macrophages with IFN-α/β attenuates the expression of inducible nitric oxide synthase through a decrease in NF-KB activation. J. Immunol. 160:2889-2895.
27. MacDonald, N. J., D. Kuhl, D. Maguire, D. Naf, P. Gallant, A. Goswammy, H. Hug, H. Büeler, M. Chaturvedi, J. de la Fuente, and C. Weissman. 1900. Different pathways mediate virus inducibility of the human IFN-αl and IFN-β genes. Cell 60:767-779.
28. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
29. Maeda, H., T. Akaike, M. Yoshida, and M. Suga. 1994. Multiple function of nitric oxide in pathophysiology and microbiology: analysis by a new nitric oxide scavenger. J. Leukoc. Biol. 56:588-592.
30. Marcinkiewicz, J. 1997. Regulation of cylokine production by eicosanoids and nitric oxide. Arch. Immunol. Ther. Exp. 45:163-167.
31. Martin, E., C. Nathan and Q.-W. Xie. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:977-984.
32. Miyamoto, M., T. Fujita, Y. Kimura, M. Maruyama, H. Harada, Y. Sudo, T. Miyata, and T. Taniguchi. 1988. Regulated expression of a gene encoding a nuclear factor, IRF-1 that specifically binds to IFN-β gene regulatory elements. Cell 54:903-913.
33. Mogensen, S. C., and J. L. Virelizier. 1987. The interferon-macrophage alliance. Interferon 8:55-84.
34. Nguyen, H., J. Hiscott, and P. M. Pitha. 1997. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev. 8:293-312.
35. Proietti, E., S. Gessani, F. Belardelli, and I. Gresser. 1986. Mouse peritoneal cells confer an antiviral state on mouse cell monolayers: role of interferon J. Virol. 57:456-463.
36. Puddu, P., L. Fantuzzi, P. Borghi, B. Varano, G. Rainaldi, E. Guillemard, W. Malorni, P. Nicaise, S. F. Wolf, F. Belardelli, and S. Gessani. 1997. IL-12 induces IFN-γ expression and secretion in mouse peritoneal macrophages. J. Immunol. 159:3490-3497.
37. Reiling, N., A. J. Ulmer, M. Duchrow, M. Ernst, H.-D. Flad, and S. Hauschildt. 1994. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 24:1941-1944.
38. Reiss, C. S., and T. Komatsu. 1998. Does nitric oxide play a critical role in viral infections? J. Virol. 72:4547-4551.
39. Riches, D. W. H. 1991. Expression of interferon-β during the triggering phase of macrophage cytocidal activation. J. Biol. Chem. 266:24785-24792.
40. Rose, J. W., K. E. Hill, Y. Wada, C. I. B. Kurtz, I. Tsunoda, R. S. Fujinami, and A. H. Cross. 1998. Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection. J. Neuroimmunol. 81:82-89.
41. Stuehr, D. J., and M. A. Marletta. 1987. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. J. Immunol. 139:518-525.
42. Taylor-Robinson, A., F. Y. Liew, A. Severn, D. Xu, S. J. McSorley, P. Garside, J. Padron, and R. S. Phillips. 1994. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24:980-984.
43. Visvanathan, K. V., and S. Goodbourn. 1989. Double-stranded RNA activates binding of NF-Kβ to an inducible element in the human β-interferon promoter. EMBO J. 8:1129-1138.
44. Wang, W. Z., A. Matsumori, T. Yamada, T. Shioi, I. Okada, S. Matsui, Y. Sato, H. Suzuki, K. Shiota, and S. Sasayama. 1997. Beneficial effect of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production. Circulation 95:245-251.
45. Weinberg, J. B., M. A. Misukonis, P. J. Shami, S. N. Mason, D. L. Sauls, W. A. Dittman, E. R. Wood, G. K. Smith, B. McDonald, K. E. Bachus, A. F. Haney, and D. L. Granger. 1995. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86:1184-1195.
46. Zhang, X., E. W. Alley, S. W. Russel, and D. C. Morrison. 1994. Necessity and sufficiency of beta interferon for nitric oxide production in mouse peritoneal macrophages. Infect. Immun. 62:33-40.
47. Zhou, A., Z. Chen, J. A. Rummage, H. Jiang, M. Kolosov, I. Kolosova, C. H. Stewart, and R. W. Leu. 1995. Exogenous interferon-γ induces endogenous synthesis of interferon-α and -β by murine macrophages for induction of nitric oxide synthase. J. Interferon Cytokine Res. 15:897-904.
48. Zidek, Z., and K. Masek. 1998. Erratic behavior of nitric oxide within the immune system: illustrative review of conflicting data and their immunopharmacological aspects. Int. J. Immunopharmacol. 20:319-343.